Persistent URL of this record https://hdl.handle.net/1887/3276575
In Collections
This item can be found in the following collections:
Phase I/Ib Clinical Trial of Sabatolimab, an Anti-TIM-3 Antibody, Alone and in Combination with Spartalizumab, an Anti-PD-1 Antibody, in Advanced Solid Tumors
- All authors
- Curigliano, G.; Gelderblom, H.; Mach, N.; Doi, T.; Tai, D.; Forde, P.M.; Sarantopoulos, J.; Bedard, P.L.; Lin, C.C.; Hodi, F.S.; Wilgenhof, S.; Santoro, A.; Sabatos-Peyton, C.A.; Longmire, T.A.; Xyrafas, A.; Sun, H.Y.; Gutzwiller, S.; Manenti, L.; Naing, A.
- Date
- 2021-07-01
- Journal
- Clinical Cancer Research
- Volume
- 27
- Issue
- 13
- Pages
- 3620 - 3629